Healthcare -
Biotechnology - NASDAQ - US
$ 46.88
1.94 %
$ 2.02 B
Market Cap
-16.8
P/E
SLNO - TOTAL CURRENT ASSETS
Total Current Assets SLNO - Soleno Therapeutics, Inc.
171 M
LAST VALUE
176.45%
2 YEAR CAGR
47.35%
5 YEAR CAGR
60.36%
10 YEAR CAGR